Home » Topics » BioWorld Science

BioWorld Science
RSS

Inflazome synthesizes new NLRP3 inflammasome inhibitors

March 15, 2021

Hunan Warrant Pharmaceuticals patents Bcr-Abl1 and/or BTK inhibitors

March 15, 2021

Chinese researchers disclose SCN10A blockers

March 15, 2021

Henlius initiates dosing in phase II/III study of HLX-10 plus bevacizumab in first-line mCRC

March 15, 2021

Targeting membrane protein starves pancreatic tumors

March 15, 2021

Many elite controllers at HIV's ground zero

March 15, 2021

Immune response research shows GM-CSF plays role in COVID-19 severity

March 15, 2021

VX-880 enters phase I/II trial for type 1 diabetes

March 12, 2021

European Commission grants conditional marketing authorization for J&J COVID-19 vaccine

March 12, 2021

Brilacidin inhibits SARS-CoV-2 in vitro

March 12, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...